Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Large-Scale Manufacturing of CMV-CD19CAR T Cells and Characterization of Their Biologic and Immunologic Properties

Xiuli Wang, PhD, Miriam Walter, Ryan Urak, Laura Lim, Vibhuti Vyas, MS, Sally Mokhtari, PhD, Don J. Diamond, PhD, Angelo Cardoso, PhD, John Zaia, MD, Stephen J. Forman, MD, Ryotaro Nakamura, MD

Blood (2019) 134 (Supplement_1): 3247.

https://doi.org/10.1182/blood-2019-131843

Published: 2019

Journal Articles

CD19-Targeting CAR-T Cell Therapy in CNS Lymphoma

Tanya Siddiqi, MD, Xiuli Wang, PhD, Joycelynne Palmer, PhD, Leslie L. Popplewell, MD FRCPA, Liana Nikolaenko, MD, Alex F. Herrera, MD, Lihua E Budde, MD PhD, Laura Lim, Vibhuti Vyas, MS, Christine E Brown, PhD, Stephen J. Forman, MD

Blood (2019) 134 (Supplement_1): 4075.

https://doi.org/10.1182/blood-2019-123765

Published: 2019

Journal Articles

Overcoming CD19 Antigen Loss in B-Cell Malignancies with CAR T Cells Targeting BAFF-R

Hong Qin, MD PhD, Zhenyuan Dong, PhD, Xiuli Wang, PhD, Wesley Cheng, BS, Diane Lynne Smith, PhD, Joo Y Song, MD, Ibrahim Aldoss, MD, Stephen J Forman, MD, Larry W Kwak, MD PhD

Blood (2019) 134 (Supplement_1): 3871.

https://doi.org/10.1182/blood-2019-129228

Published: 2019

Journal Articles

CD19-CAR Therapy Using Naive/Memory or Central Memory T Cells Integrated into the Autologous Stem Cell Transplant Regimen for Patients with B-NHL

Leslie Popplewell, MD, Xiuli Wang, PhD, Suzette Blanchard, PhD, Jamie Wagner, BS, Araceli Naranjo, BS, Arencibia Adria, BS, Jinny Paul, PhD, Laura Lim, Wen-Chung Chang, PhD, Elizabeth E Budde, MD PhD, Sandra Thomas, PhD, Christine Brown, PhD, Stephen J Forman

Blood (2018) 132 (Supplement 1): 610.

https://doi.org/10.1182/blood-2018-99-119650

Published: 2018

Journal Articles

The Cerebroventricular Environment Reprograms Locally Infused CAR T Cells for Superior Activity Against Both CNS and Systemic B Cell Lymphoma

Xiuli Wang, PhD, Christian Huynh, Ryan Urak, Miriam Walter, Lihong Weng, MD, Laura Lim, Vibhuti Vyas, Brenda Aguilar, Alfonso Brito, Aniee Sarkissian, Achini Bandara, PhD, Elizabeth E Budde, MD PhD, Leslie Popplewell, MD, Tanya Siddiqi, MD, Christine Brown, PhD, Stephen J Forman

Blood (2018) 132 (Supplement 1): 965.

https://doi.org/10.1182/blood-2018-99-119335

Published: 2018

Journal Articles

Adult Patients with ALL Treated with CD62L+ T Naïve/Memory-Enriched T Cells Expressing a CD19-CAR Mediate Potent Antitumor Activity with a Low Toxicity Profile

Samer K. Khaled, MD, Suzette Blanchard, PhD, Xiuli Wang, PhD, Jamie Wagner, BS, Araceli Naranjo, BS, Jennifer Simpson, Sandra Thomas, PhD, Julie Ostberg, PhD, Christine Brown, PhD, Stephen J Forman

Blood (2018) 132 (Supplement 1): 4016.

https://doi.org/10.1182/blood-2018-99-119883

Published: 2018

Journal Articles

Targeted Delivery of CpG-Mir-146a Mimic Oligonucleotides As a Therapeutic Strategy to Reduce NF-Κb-Mediated Pathogenic Inflammation and Myeloid Leukemia Progression

Yu-Lin SU, PhD, Zhuoran Zhang, PhD, Mati Mann, PhD, Xiuli Wang, PhD, Le Xuan Truong Nguyen, PhD, Bin Zhang, PhD, Ling Li, PhD, Piotr Swiderski, PhD, Mark Boldin, MD PhD, Stephen J Forman, Guido Marcucci, Marcin Kortylewski, PhD

Blood (2018) 132 (Supplement 1): 3501.

https://doi.org/10.1182/blood-2018-99-115637

Published: 2018

Journal Articles

Novel BAFF-R CAR T-Cell Therapy for CD19 Antigen-Loss Relapsed B Cell Tumors

Hong Qin, MD PhD, Zhenyuan Dong, PhD, Xiuli Wang, PhD, Wesley Cheng, BS, Diane Lynne Smith, PhD, Joo Y Song, MD, Ibrahim Aldoss, MD, Markus Muschen, MD, Stephen J Forman, Larry W Kwak, MD PhD

Blood (2018) 132 (Supplement 1): 1411.

https://doi.org/10.1182/blood-2018-99-117513

Published: 2018

Journal Articles

CAR-T Cells Targeting BAFF-Receptor for B-Cell Malignancies: A Potential Alternative to CD19

Hong Qin, MD PhD, Zhenyuan Dong, PhD, Fen Wen, MD, Wesley Cheng, BS, Han Sun, PhD, Guowei Wei, PhD, Diane Lynne Smith, PhD, Sattva S. Neelapu, MD, Xiuli Wang, PhD, Stephen J. Forman, MD FACP, Larry W Kwak, MDPhD

Blood (2017) 130 (Supplement 1): 3180.

https://doi.org/10.1182/blood.V130.Suppl_1.3180.3180

Published: 2017

Journal Articles

Remissions of Acute Myeloid Leukemia and Blastic Plasmacytoid Dendritic Cell Neoplasm Following Treatment with CD123-Specific CAR T Cells: A First-in-Human Clinical Trial

Lihua Budde, MD PhD, Joo Y Song, MD, Young Kim, MD, Suzette Blanchard, PhD, Jamie Wagner, BS, Anthony S. Stein, MD, Lihong Weng, MD, Marissa Del Real, PhD, Rochelle Hernandez, Emanuela Marcucci, Jennifer K Shepphird, PhD, Xiuli Wang, PhD, Brent Wood, MDPhD, Guido Marcucci, MD, Christine E Brown, PhD, Stephen J. Forman, MD FACP

Blood (2017) 130 (Supplement 1): 811.

https://doi.org/10.1182/blood.V130.Suppl_1.811.811

Published: 2017

Journal Articles

Phase I Studies of Cellular Immunotherapy Using Central Memory Derived-CD19-Specific T Cells Following Autologous Stem Cell Transplantation for Patients with High-Risk Intermediate Grade B-Lineage Non-Hodgkin Lymphoma

Leslie Popplewell, MD, Xiuli Wang, PhD, Araceli Naranjo, BS, Suzette Blanchard, PhD, Jamie Wagner, BS, ChingLam Wong, BS, Ryan Urak, MS, Wen-Chung Chang, MS, Samer K Khaled, MD, Tanya Siddiqi, MD, Elizabeth E. Budde, MD PhD, Jingying Xu, PhD, Brenda Chang, BS, Sandra H. Thomas, PhD, Stanley R. Riddell, MD, Christine Brown, PhD, Michael C Jensen, MD, Stephen J. Forman, MD

Blood (2015) 126 (23): 930.

https://doi.org/10.1182/blood.V126.23.930.930

Published: 2015

Journal Articles

Ex Vivo AKT Inhibition Promotes the Generation of Potent CD19CAR T Cells for Adoptive Immunotherapy

Ryan Urak, MS, ChingLam Wong, BS, Wen-Chung Chang, MS, Elizabeth E. Budde, MD PhD, Christine Brown, PhD, Sandra H. Thomas, PhD, Stephen J. Forman, MD, Xiuli Wang, PhD

Blood (2015) 126 (23): 3086.

https://doi.org/10.1182/blood.V126.23.3086.3086

Published: 2015

Journal Articles

CS-1 Re-Directed Central Memory T Cell Therapy for Multiple Myeloma

Xiuli Wang, PhD, ChingLam W Wong, BS, Ryan Urak, MS, Wen-Chung Chang, MS, Elizabeth E. Budde, MD PhD, Christine Brown, PhD, Stephen J. Forman, MD

Blood (2014) 124 (21): 1114.

https://doi.org/10.1182/blood.V124.21.1114.1114

Published: 2014

Journal Articles

Targeting Of Leukemia Stem Cells By Interfering With Niches Using CD44 Variant 6 Chimeric Antigen Receptor Redirected Central Memory T Cells

Xiuli Wang, PhD, ChingLam W Wong, BS, Ryan Urak, MS, Armen Mardiros, MS, Wen-Chung Chang, MS, Ellie Taus, BS, Lihua E Budde, MD, PhD, Julie R Ostberg, Ph.D, Christine Brown, PhD, Stephen J. Forman, MD

Blood (2013) 122 (21): 4497.

https://doi.org/10.1182/blood.V122.21.4497.4497

Published: 2013

Journal Articles

Research of Subset and Function of Th Cells in Bone Marrow of Myelodysplastic Syndrome Patients.

Xiuli Wang, PhD, De Pei Wu, MDPhD, Guangsheng He, MD, PhD, Miao Miao, PhD, Aining Sun, PhD

Blood (2005) 106 (11): 4913.

https://doi.org/10.1182/blood.V106.11.4913.4913

Published: 2005

Journal Articles

Subsets and Function Changes of Th Cells in the Bone Marrow of Patients with Immune Related Pancytopenia.

Guangsheng He, MD, PhD, Xiuli Wang, PhD, De Pei Wu, MD, Ph.D, Aining Sun, PhD, Zhengming Jin, PhD

Blood (2005) 106 (11): 3762.

https://doi.org/10.1182/blood.V106.11.3762.3762

Published: 2005

NARROW

Large-Scale Manufacturing of CMV-CD19CAR T Cells and Characterization of Their Biologic and Immunologic Properties

CD19-Targeting CAR-T Cell Therapy in CNS Lymphoma

Overcoming CD19 Antigen Loss in B-Cell Malignancies with CAR T Cells Targeting BAFF-R

CD19-CAR Therapy Using Naive/Memory or Central Memory T Cells Integrated into the Autologous Stem Cell Transplant Regimen for Patients with B-NHL

The Cerebroventricular Environment Reprograms Locally Infused CAR T Cells for Superior Activity Against Both CNS and Systemic B Cell Lymphoma

Adult Patients with ALL Treated with CD62L+ T Naïve/Memory-Enriched T Cells Expressing a CD19-CAR Mediate Potent Antitumor Activity with a Low Toxicity Profile

Targeted Delivery of CpG-Mir-146a Mimic Oligonucleotides As a Therapeutic Strategy to Reduce NF-Κb-Mediated Pathogenic Inflammation and Myeloid Leukemia Progression

Novel BAFF-R CAR T-Cell Therapy for CD19 Antigen-Loss Relapsed B Cell Tumors

CAR-T Cells Targeting BAFF-Receptor for B-Cell Malignancies: A Potential Alternative to CD19

Remissions of Acute Myeloid Leukemia and Blastic Plasmacytoid Dendritic Cell Neoplasm Following Treatment with CD123-Specific CAR T Cells: A First-in-Human Clinical Trial

Phase I Studies of Cellular Immunotherapy Using Central Memory Derived-CD19-Specific T Cells Following Autologous Stem Cell Transplantation for Patients with High-Risk Intermediate Grade B-Lineage Non-Hodgkin Lymphoma

Ex Vivo AKT Inhibition Promotes the Generation of Potent CD19CAR T Cells for Adoptive Immunotherapy

CS-1 Re-Directed Central Memory T Cell Therapy for Multiple Myeloma

Targeting Of Leukemia Stem Cells By Interfering With Niches Using CD44 Variant 6 Chimeric Antigen Receptor Redirected Central Memory T Cells

Research of Subset and Function of Th Cells in Bone Marrow of Myelodysplastic Syndrome Patients.

Subsets and Function Changes of Th Cells in the Bone Marrow of Patients with Immune Related Pancytopenia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only